Functional contributions of carbohydrate on AIDS virus glycoprotein

Yale Journal of Biology and Medicine

Volumn 83, Issue 4, 2010, Pages 201-208

  Stansell, Elizabeth ^a   Desrosiers, Ronald C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CYANOVIRIN N; EPITOPE; GLYCOPROTEIN GP 120; LECTIN; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARBOHYDRATE ANALYSIS; CERCOCEBUS; COMPLEX FORMATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC DIFFERENCE; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN FUNCTION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS REPLICATION;

ANIMALS; GLYCOPROTEINS; HIV-1; HUMANS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS;

AIDS VIRUS; CERCOCEBUS TORQUATUS ATYS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79953134012     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Walter P, Lingappa VR. Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol. 1986;2:499-516.
2. Earl PL, Doms RW, Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci USA. 1990;87:648-52.
3. Earl PL, Moss B, Doms RW. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J Virol. 1991;65:2047-55.
4. Otteken A, Earl PL, Moss B. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates. J Virol. 1996;70:3407-15.
5. Morikawa Y, Barsov E, Jones I. Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin. J Virol. 1993;67:3601-4.
6. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, et al. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature. 1992;360:358-61.
7. Ono A. Relationships between plasma membrane microdomains and HIV-1 assembly. Biol Cell. 2010;102:335-50.
8. Benaroch P, Billard E, Gaudin R, Schindler M, Jouve M. HIV-1 assembly in macrophages. Retrovirology. 2010;7:29.
9. Shakin-Eshleman SH, Spitalnik SL, Kasturi L. The amino acid at the X position of an Asn- X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency. J Biol Chem. 1996;271:6363-6.
10. Kiely ML, McKnight GS, Schimke RT. Studies on the attachment of carbohydrate to ovalbumin nascent chains in hen oviduct. J Biol Chem. 1976;251:5490-5.
11. Sefton BM. Immediate glycosylation of Sindbis virus membrane proteins. Cell. 1977;10:659-68.
12. Caccam JF, Jackson JJ, Eylar EH. The biosynthesis of mannose-containing glycoproteins: a possible lipid intermediate. Biochem Biophys Res Commun. 1969;35:505-11.
13. Waechter CJ, Lennarz WJ. The role of polyprenol-linked sugars in glycoprotein synthesis. Annu Rev Biochem. 1976;45:95-112.
14. Tabas I, Schlesinger S, Kornfeld S. Processing of high mannose oligosaccharides to form complex type oligosaccharides on the newly synthesized polypeptides of the vesicular stomatitis virus G protein and the IgG heavy chain. J Biol Chem. 1978;253:716-22.
15. Kornfeld S, Li E, Tabas I. The synthesis of complex-type oligosaccharides. II. Characterization of the processing intermediates in the synthesis of the complex oligosaccharide units of the vesicular stomatitis virus G protein. J Biol Chem. 1978;253:7771-8.
16. Tabas I, Kornfeld S. The synthesis of complextype oligosaccharides. III. Identification of an alpha-D-mannosidase activity involved in a late stage of processing of complex-type oligosaccharides. J Biol Chem. 1978;253:7779-86.
17. Yamashita K, Tachibana Y, Kobata A. The structures of the galactose-containing sugar chains of ovalbumin. J Biol Chem. 1978;253:3862-9.
18. Tian E, Ten Hagen KG. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J. 2009;26:325-34.
19. Strous GJ. Initial glycosylation of proteins with acetylgalactosaminylserine linkages. Proc Natl Acad Sci USA. 1979;76:2694-8.
20. Hearn VM, Goodwin SD, Watkins WM. Biosynthesis of blood group active glycoproteins: a peptidyl: alpha-N-acetylgalactosaminyltransferase from human submaxillary gland and stomach mucosal tissue. Biochem Biophys Res Commun. 1970;41:1279-86.
21. Jensen PH, Kolarich D, Packer NH. Mucintype O-glycosylation--putting the pieces together. FEBS J. 2010;277:81-94.
22. Trottein F, Schaffer L, Ivanov S, Paget C, Vendeville C, et al. Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages. Glycoconj J. 2009;26:1259-74.
23. Gruters RA, Neefjes JJ, Tersmette M, de Goede RE, Tulp A, et al. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 1987;330:74-7.
24. Tyms AS, Berrie EM, Ryder TA, Nash RJ, Hegarty MP, et al. Castanospermine and other plant alkaloid inhibitors of glucosidase activity block the growth of HIV. Lancet. 1987;2:1025-6.
25. Walker BD, Kowalski M, Goh WC, Kozarsky K, Krieger M, et al. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc Natl Acad Sci USA. 1987;84: 8120-4.
26. Fenouillet E, Jones IM. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J Gen Virol. 1995;76(Pt 6):1509-14.
27. Li Y, Luo L, Rasool N, Kang CY. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J Virol. 1993;67:584-8.
28. Pikora C, Wittish C, Desrosiers RC. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4. J Virol. 2005;79:12575-83.
29. Reitter JN, Desrosiers RC. Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein. J Virol. 1998;72:5399-407.
30. Bahraoui E, Benjouad A, Guetard D, Kolbe H, Gluckman JC, et al. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans. AIDS Res Hum Retroviruses. 1992;8:565-73.
31. Benjouad A, Babas T, Montagnier L, Bahraoui E. N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor. Biochem Biophys Res Commun. 1993;190:311-9.
32. Binley JM, Wyatt R, Desjardins E, Kwong PD, Hendrickson W, et al. Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120. AIDS Res Hum Retroviruses. 1998;14:191-8.
33. Fenouillet E, Clerget-Raslain B, Gluckman JC, Guetard D, Montagnier L, et al. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis. J Exp Med. 1989;169:807-22.
34. Hu H, Shioda T, Moriya C, Xin X, Hasan MK, et al. Infectivities of human and other primate lentiviruses are activated by desialy- lation of the virion surface. J Virol. 1996;70:7462-70.
35. Means RE, Desrosiers RC. Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J Virol. 2000;74:11181-90.
36. Reitter JN, Means RE, Desrosiers RC. A role for carbohydrates in immune evasion in AIDS. Nat Med. 1998;4:679-84.
37. Wei X, Decker JM, Wang S, Hui H, Kappes JC, et al. Antibody neutralization and escape by HIV-1. Nature. 2003;422:307-12.
38. Burns DP, Collignon C, Desrosiers RC. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J Virol. 1993;67:4104-13.
39. Chackerian B, Rudensey LM, Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol. 1997;71:7719- 27.
40. Duenas-Decamp MJ, Peters P, Burton D, Clapham PR. Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop. J Virol. 2008;82:5807-14.
41. Johnson WE, Sanford H, Schwall L, Burton DR, Parren PW, et al. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J Virol. 2003;77:9993-10003.
42. Kinsey NE, Anderson MG, Unangst TJ, Joag SV, Narayan O, et al. Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology. 1996;221:14-21.
43. Ly A, Stamatatos L. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti- V3 loop and anti-CD4 binding site antibodies. J Virol. 2000;74:6769-76.
44. Mori K, Yasutomi Y, Ohgimoto S, Nakasone T, Takamura S, et al. Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain. J Virol. 2001;75:4023-8.
45. Rudensey LM, Kimata JT, Long EM, Chackerian B, Overbaugh J. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol. 1998;72:209-17.
46. Sato S, Yuste E, Lauer WA, Chang EH, Morgan JS, et al. Potent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo. J Virol. 2008;82:9739-52.
47. Schonning K, Jansson B, Olofsson S, Nielsen JO, Hansen JS. Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology. 1996;218:134-40.
48. Li Y, Cleveland B, Klots I, Travis B, Richardson BA, et al. Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. J Virol. 2008;82:638-51.
49. Cole KS, Steckbeck JD, Rowles JL, Desrosiers RC, Montelaro RC. Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3. J Virol. 2004;78:1525-39.
50. Yuste E, Bixby J, Lifson J, Sato S, Johnson W, et al. Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies. J Virol. 2008;82:12472-86.
51. Stansell E, Canis K, Haslam SM, Dell A, Desrosiers RC. Simian Immunodeficiency Virus from Sooty Mangabey and Rhesus Macaque is Modified with O-linked Carbohydrate. J Virol. Forthcoming 2010.
52. Ortiz M, Kaessmann H, Zhang K, Bashirova A, Carrington M, et al. The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates. Genes Immun. 2008;9:483-92.
53. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. DCSIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587-97.
54. Hong PW, Nguyen S, Young S, Su SV, Lee B. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120. J Virol. 2007;81:8325-36.
55. Gringhuis SI, van der Vlist M, van den Berg LM, den Dunnen J, Litjens M, et al. HIV-1 exploits innate signaling by TLR8 and DCSIGN for productive infection of dendritic cells. Nat Immunol. 2010;11:419-26.
56. Shan M, Klasse PJ, Banerjee K, Dey AK, Iyer SP, et al. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 2007;3:e169.
57. Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, et al. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses. 2006;22:757-62.
58. Daly LM, Johnson PA, Donnelly G, Nicolson C, Robertson J, et al. Innate IL-10 promotes the induction of Th2 responses with plasmid DNA expressing HIV gp120. Vaccine. 2005;23:963-74.
59. Geijtenbeek TB, van Vliet SJ, Engering A, Hart BA, van Kooyk Y. Self- and nonselfrecognition by C-type lectins on dendritic cells. Annu Rev Immunol. 2004;22:33-54.
60. Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, et al. Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol. 2002;3:975-83.
61. Ji X, Chen Y, Faro J, Gewurz H, Bremer J, et al. Interaction of human immunodeficiency virus (HIV) glycans with lectins of the human immune system. Curr Protein Pept Sci. 2006;7:317-24.
62. Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol. 2000;81:949-55.
63. Litvack ML, Palaniyar N. Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation. Innate Immun. 2010;16:191-200.
64. Spear GT, Zariffard MR, Xin J, Saifuddin M. Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin. Immunology. 2003;110:80-5.
65. Ji X, Gewurz H, Spear GT. Mannose binding lectin (MBL) and HIV. Mol Immunol. 2005;42:145-52.
66. Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother. 1997;41:1521-30.
67. Tsai CC, Emau P, Jiang Y, Tian B, Morton WR, et al. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res Hum Retroviruses. 2003;19:535-41.
68. Balzarini J, Van Laethem K, Peumans WJ, Van Damme EJ, Bolmstedt A, et al. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with Nglycan deletions in their gp120 envelopes. J Virol. 2006;80:8411-21.
69. Huskens D, Vermeire K, Vandemeulebroucke E, Balzarini J, Schols D. Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent. Int J Biochem Cell Biol. 2008;40:2802-14.
70. Huskens D, Ferir G, Vermeire K, Kehr JC, Balzarini J, et al. Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin- N but a much higher safety profile. J Biol Chem. 2010;285:24845-54.
71. Stansell E, Desrosiers RC. Fundamental Difference in the Content of High-Mannose Carbohydrate in the HIV-1 and HIV-2 Lineages. J Virol. 2010;84:8998-9009.
72. Balzarini J, Van Laethem K, Hatse S, Froeyen M, Van Damme E, et al. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis. Mol Pharmacol. 2005;67:1556-65.
73. Ploquin MJ, Diop OM, Sol-Foulon N, Mortara L, Faye A, et al. DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm. J Virol. 2004;78:798-810.
74. Pohlmann S, Baribaud F, Lee B, Leslie GJ, Sanchez MD, et al. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J Virol. 2001;75:4664-72.
75. Yu Kimata MT, Cella M, Biggins JE, Rorex C, White R, et al. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J Virol. 2002;76:11827-36.
76. Wu L, Bashirova AA, Martin TD, Villamide L, Mehlhop E, et al. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc Natl Acad Sci USA. 2002;99:1568-73.